All Posts

How can we provide more precise diagnostics, better treatment and faster responses to disease development? The answer may lie in metabolomics – and this was the topic when Oslo University Hospital (OUS) in collaboration with Health2B brought together researchers, clinicians and partners for a professional day in Oslo on September 24. Full article: https://www.oslo-universitetssykehus.no/avdelinger/klinikk-for-laboratoriemedisin/metabolomikk-fremtiden-for-persontilpasset-medis

Hanne Bendiksen Skogvold, Elise Sandås Sand & Katja Benedikte Prestø Elgstøen (Corresponding author) DOI: https://doi.org/10.1007/978-1-0716-4116-3_2 Abstract: Metabolomics can be used for a multitude of purposes, including monitoring of treatment effects and for increasing the knowledge of the pathophysiology of a wide range of diseases. Global (commonly referred to as “untargeted”) metabolomics is hypothesis-generating and provides the opportunity to discover new biomarkers

Exploring nuclear magnetic resonance spectroscopy for the analysis of dried blood spots Cristina Alexandrescu , Sander Johannes Thorbjørnsen Guttorm , Katja Benedikte Prestø Elgstøen , Frode Rise , Steven Ray Wilson (corresponding author) The study by Alexandrescu et al. (2025) explores the feasibility of using ^1H NMR spectroscopy to analyze dried blood spots (DBS) for metabolomic profiling. DBS sampling has long been used in newborn screening and clinical assays due to its

Metabolomics er et spennende felt som har fått mye oppmerksomhet de siste årene. Det handler om studiet av metabolitter, som er små...

Metabolomics er et spennende og raskt voksende felt innen vitenskapen. Det handler om å studere metabolitter, som er små molekyler som...